Related Experiment Video

Updated: May 13, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Adjuvant treatment of melanoma

J A Moreno Nogueira1, M Valero Arbizu, R Pérez Temprano

  • 1Department of Oncology, Virgen del Rocio University Hospital, Royal Academy of Medicine, 41001 Seville, Spain.

ISRN Dermatology
|March 12, 2013
PubMed

Insights

High-risk melanoma patients benefit from adjuvant Interferon-α 2b therapy, improving disease-free survival. Future treatments may combine targeted therapies with chemotherapy or interferon for better melanoma outcomes.

Area of Science:

  • Oncology
  • Dermatology
  • Cancer Research

Background:

  • Melanoma is a significant cause of skin cancer mortality, with metastatic disease having a poor prognosis.
  • Key oncogenes like BRAF, NRAS, c-Kit, GNA11, and GNAQ drive melanoma proliferation and angiogenesis.
  • Current treatment for localized melanoma involves surgery, with lymphadenectomy for nodal involvement.

Purpose of the Study:

  • To review the current understanding of melanoma pathogenesis and treatment options.
  • To highlight the role of adjuvant therapy in high-risk melanoma.
  • To discuss future therapeutic strategies for altering melanoma's natural history.

Main Methods:

  • Review of existing literature on melanoma genetics, prognosis, and treatment.
  • Analysis of the efficacy of adjuvant Interferon-α 2b therapy.
  • Exploration of potential future therapeutic targets and combinations.

Main Results:

  • High-risk melanomas have a substantial relapse rate (50-80%) necessitating adjuvant treatment.
  • High-dose Interferon-α 2b is the only established adjuvant therapy shown to improve disease-free and potentially overall survival.
  • Targeted therapies are emerging, with potential for combination with chemotherapy and/or interferon.

Conclusions:

  • Adjuvant Interferon-α 2b offers a survival benefit for high-risk melanoma patients.
  • Future melanoma treatment will likely involve personalized, targeted therapies combined with traditional approaches.
  • Further research is needed to optimize adjuvant and combination therapies to improve melanoma patient outcomes.

More Related Videos

A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...